Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Subcontract opportunity from Department Of Defense was posted on October 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Dibucaine Ointment Manufacturer

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--VA Loma Linda FDG
Solicitation # 36C26227Q0133
The Department of Veterans Affairs Loma Linda Healthcare System is conducting a Sources Sought and Request for Information (RFI) to identify qualified sources for a future single-award, Firm Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract. The scope of work involves the procurement of radiopharmaceutical supplies, specifically 18-FDG, F18 NaF, and Bulk F-18 FDG. The intended period of performance consists of a base year starting December 15, 2026, followed by four option years ending December 14, 2031. The government is seeking providers capable of delivering sterile doses for intravenous injection that are compatible with the NMIS System and meet strict quality standards, including a radioactivity variance no greater than plus or minus 20 percent at the time of calibration. Deliveries will be made to the Nuclear Medicine Section at the Loma Linda facility, with routine orders required by the next business day and emergency orders required on the same day. The contractor must be licensed by the State of Operation and the Nuclear Regulatory Commission or an Agreement State Agency, and delivery personnel must be trained in Department of Transportation requirements and radiation safety. Interested parties must submit a capabilities statement, business size representations under NAICS 325412, and SAM.gov entity information to [email hidden] by November 20, 2026. This notice is for planning purposes only and does not constitute a formal solicitation.
262-NETWORK Contract Office 22 (36C262)

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

Show more

This subcontract involves the manufacture of USP-standard rectal ointment containing 1 percent active Dibucaine for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The manufacturer must produce the ointment according to strict USP standards, ensuring temperature controls are maintained between 15 and 30 degrees Celsius and providing a finished product with a 36-month shelf life. Eligible providers must operate out of an FDA-registered facility that is compliant with current Good Manufacturing Practices. Additionally, the contractor must adhere to the Buy American Act and the Berry Amendment. Performance for this project is associated with Eielson Air Force Base under NAICS code 325412.

General Info

Manufacture USP Dibucaine rectal ointment for DoD via FDA-registered, Buy American compliant facility.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

EIELSON AFB, AK, 99702-2325, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-27-T-0106.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DIBUCAINE OINTMENT

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Manufactures USP-standard rectal ointment for prime contractors on DLA Troop Support Medical Supply Chain Pharm FSA projects. Formulates and produces ointment with 1 percent active Dibucaine ingredient per USP standards, maintaining temperature controls between 15 to 30 degrees Celsius. Requires FDA-registered facility compliant with cGMP, Buy American Act, and Berry Amendment. Delivers finished Dibucaine Ointment with a 36-month shelf life.

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS